Search Results 1531-1540 of 16727 for Ureaplasma urealyticum

  1. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris ...

  2. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

    Active infection requiring systemic treatment within 28 days before the first dose of study treatment as per the protocol template. No concomitant treatment ...

  3. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

    Identified active infection and/or fever (defined as axillary or forehead temperature ≥ 37.4°C, oral temperature ≥ 37.7°C, or rectal or ear temperature ...

  4. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

    Has an active infection requiring systemic therapy. Has a history or current evidence of any condition, therapy, or laboratory abnormality that might ...

  5. Mayo Clinic Minute Zika Virus Video Audio

    “Zika virus in an emerging infection seen largely right now in South America, although there seems to be some migration father north.” Dr. Pritish Tosh is ...

  6. Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery - Mayo Clinic

    Other current active infection requiring systemic antibiotic treatment. Inadequate hepatic function, defined as total bilirubin or alanine aminotransferase ...

  7. A Study to Evaluate Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

    Untreated or uncontrolled active bacterial, fungal, or viral infection; - Participation in other interventional clinical studies within 30 days prior to Day ...

  8. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    Severe or uncontrolled intercurrent illness/infection. Concurrent administration of any other investigational agent considered to have potential efficacy in ...

  9. Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  10. Mayo Clinic

    Listeria infection · Liver cancer · Melanoma · Menopause · Mild cognitive impairment (MCI) · Myelodysplastic syndromes · Nail fungus · Nicotine dependence ...